Narrowing the gap in treatment of depression

被引:36
作者
Harman, JS [1 ]
Mulsant, BH [1 ]
Kelleher, KJ [1 ]
Schulberg, HC [1 ]
Kupfer, DJ [1 ]
Reynolds, CF [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA
关键词
depression; health services accessibility; time factors;
D O I
10.2190/Q3VY-T8V9-30MA-VC5C
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Although effective treatments for depression exist, under or non-treatment of depression is common. Efforts were made in the early 1990s to improve recognition and treatment of depression, with many of those efforts targeted at groups most vulnerable to under-treatment. The purpose of this study is to assess treatment rates in 1993-1994 and 1996-1997. Method: Using nationally representative surveys of office-based practice covering the years 1993, 1994, 1996, and 1997, we obtained estimates of visits by adults in which depression was diagnosed and a prescription for antidepressant medication and/or psychotherapy was provided or ordered. Results: The proportion of physician office visits in which a depression diagnosis was recorded did not change from 1993-1994 (3.48 percent) to 1996-1997 (3.40 percent). However, the rate of antidepressant prescription or psychotherapy rose from 74.2 percent of visits with a depression diagnosis in 1993-1994 to 82.3 percent of these visits in 1996-1997. Significantly lower rates of treatment for depression during office visits made by African American patients, elderly patients, and patients on Medicaid occurred in 1993-1994, but were not evident in 1996-1997, reflecting improved rates of depression treatment in these populations. Conclusions: Although rates of diagnosis of depression during office visits have not increased, treatment rates for depression are improving among those who are diagnosed, including groups of people who historically were less likely to be offered treatment. Additional efforts to improve recognition and diagnosis of depression in ambulatory medical practice and to improve dissemination of treatment are needed.
引用
收藏
页码:239 / 253
页数:15
相关论文
共 24 条
[1]  
BLAZER D, 1999, MARKED DIFFERENCES A
[2]  
BROWN DR, 1995, AM J PSYCHIAT, V152, P373
[3]  
BRYANT E, 1988, VITAL HLTH STAT 2, V108, P1
[4]  
Depression Guideline Panel, 1993, AHCPR PUBL, V2
[5]   DIAGNOSIS AND TREATMENT OF DEPRESSION IN LATE LIFE [J].
FRIEDHOFF, AJ ;
BALLENGER, J ;
BELLACK, AS ;
CARPENTER, WT ;
CHUI, HC ;
DOBROF, R ;
FITZPATRICK, JJ ;
FREEMAN, R ;
HENINGER, GR ;
LAVORI, PW ;
MERIKANGAS, KR ;
RASCHKO, R ;
STORANDT, M ;
WILLIAMS, ME .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (08) :1018-1024
[6]  
HALL D, 1997, HDB PSYCHIAT DRUGS
[7]   The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder [J].
Judd, LL ;
Akiskal, HS ;
Paulus, MP .
JOURNAL OF AFFECTIVE DISORDERS, 1997, 45 (1-2) :5-17
[8]   ADEQUACY AND DURATION OF ANTIDEPRESSANT TREATMENT IN PRIMARY CARE [J].
KATON, W ;
VONKORFF, M ;
LIN, E ;
BUSH, T ;
ORMEL, J .
MEDICAL CARE, 1992, 30 (01) :67-76
[9]   Diagnosis and treatment of depression in late life - Consensus statement update [J].
Lebowitz, BD ;
Pearson, JL ;
Schneider, LS ;
Reynolds, CF ;
Alexopoulos, GS ;
Bruce, ML ;
Conwell, Y ;
Katz, IR ;
Meyers, BS ;
Morrison, MF ;
Mossey, J ;
Niederehe, G ;
Parmelee, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (14) :1186-1190
[10]  
*MED EC CO INC, 1997, PHYS DESK REF